Table 1.
Baseline characteristics for study population
| n=155 | |
| Age (years) | 56±9 |
| Male gender | 132 (85%) |
| Diabetes mellitus | 9 (6%) |
| Known hypertension | 47 (30%) |
| Hypercholesterolaemia | 29 (19%) |
| Current cigarette smoking | 79 (51%) |
| Time from symptom onset to PCI (hours)* | 3.3 (2.2–4.5) |
| Anterior infarction | 98 (63%) |
| Medication at discharge | |
| ACE-inhibitors/ATII antagonists | 147 (95%) |
| Beta-blockers | 146 (94%) |
| Cardiac magnetic resonance imaging | |
| LVEF (%) | 44±8 |
| End-diastolic volume (mL/m2) | 98±16 |
| End-systolic volume (mL/m2) | 56±14 |
| Infarct size (g)† | 22±12 |
| Presence of microvascular obstruction | 90 (58%) |
*Median (25th–75th percentile).
†Analysis available in 132 patients.
AT, angiotensin; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention.